A randomized double-blind placebo-controlled multicenter clinical trial of Henggu Bone Injury Healing Agent in the treatment of long tubular bone fractures of the lower extremities (Qi stagnation and blood stasis syndrome)

Authors
Category Primary study
Registry of TrialsInternational Traditional Medicine Clinical Trial Registry
Year 2025
This article has no abstract
Epistemonikos ID: 00b5d5fb96dddff43ff94314c0ec7096d7da5156
First added on: Apr 23, 2026